NCT00856310 A Single-Dose Study of the Safety and Tolerability of REGN475(SAR164877) in Healthy Subjects Status COMPLETED Phase PHASE1
NCT00855530 Long Term Safety and Tolerability of SR58611 in Patients With Major Depressive Disorder Status COMPLETED Phase PHASE3
NCT00851903 Evaluation of Insulin Glargine in Combination With Sitagliptin in Type 2 Diabetes Patients: EASIE Extension Trial Status COMPLETED Phase PHASE3
NCT00851084 Study of Aflibercept And Modified FOLFOX6 As First-Line Treatment In Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00847834 Irbesartan-Hydrochlorothiazide Phase IV Study: Treatment of Hypertension in Chinese Population Status COMPLETED Phase PHASE4
NCT00846196 A Study to Assess the Bioequivalence of Different Formulations of Risedronate in Healthy Male and Female Subjects Status COMPLETED Phase PHASE1
NCT00845429 Immunogenicity of a Split, Cell-Based, Inactivated, Trivalent Influenza Vaccine in Healthy Adult Subjects Status COMPLETED Phase PHASE2
NCT00837746 Analysis of Iliac Crest Biopsies From Patients Receiving Risedronate Status COMPLETED Phase N/A
NCT00833859 Neoadjuvant Gemcitabine, Docetaxel, and Capecitabine in Combination With Stereotactic Radiosurgery Status TERMINATED Phase PHASE2
NCT00833703 Long Term Safety of Clopidogrel in Neonates/Infants With Systemic to Pulmonary Artery Shunt Palliation Status COMPLETED Phase PHASE3
NCT00832338 Trial Using Docetaxel Cytoxan in Breast Cancers With High Recurrence Scores Status TERMINATED Phase PHASE2
NCT00831571 Prospective Analysis of Hypersensitivity Reactions to Oxaliplatin Status COMPLETED Phase N/A
NCT00830830 TREAD-20 Extension - Treatment of Knee Pain Due to Osteoarthritis Status COMPLETED Phase PHASE4
NCT00827411 Double Randomization of a Monitoring Adjusted Antiplatelet Treatment Versus a Common Antiplatelet Treatment for DES Implantation, and Interruption Versus Continuation of Double Antiplatelet Therapy Status COMPLETED Phase PHASE4
NCT00826852 Weekly Docetaxel and Four Weekly Carboplatin in Non-small Cell Lung Cancer Carbo-Tax Status COMPLETED Phase PHASE2
NCT00825058 Efficacy and Safety of SR58611 Compared to Placebo and Paroxetine Status COMPLETED Phase PHASE3